Dementia Mental and Behavioural Disorders Unspecified dementia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The following inclusion criteria were set for institution and patient level of the trial. Institution Level 1. At least two wards of one nursing home must take part in the study that provide together at least 30 residents with dementia 2. The care of the residents have to take place most of the day in their ward Patient level 1. Informed consent 2. Diagnosis of dementia 3. Living not less than 14 days in the ward According to the Federal Statistical Office we expect that most of the patients are > 65 years and around 70% of the patients in our study sample will be women and 30% men.
Exclusion criteria
Exclusion criteria: The following exclusion criteria were set for institution and patient level of the trial Institution level 1. Nursing homes size < 30 2. Some kind of day care is integrated in the institution for people with dementia 3. Reconstruction work on the participated unit and participation in any other research project at the same time that bond personal resources Patient level 1. Schizophrenia or any other kind of psychiatric diseases (found in the medical documentation)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Challenging behavior of residents with dementia measured with the NPI-NH proxy-measurement. Measured at baseline (T0) and after that every 3 months (T1-T6) over a period of 19 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients: 1. Quality of Life of people with Dementia measured with the QUALIDEM proxy- measurement 2. The Defined Daily Dose (DDD) of Psychotropic Drugs Staff: 1. Burnout of the nursing staff with will be measured with the Copenhagen Burnout Inventory (CBI) 2. The dementia-specific burden on nursing staff will be assessed with the German BelaDem Questionnaire. 3. The vocational action competence of the nursing staff will be measured with the German questionnaire ?Kompetenz ? Reflektions ? Inventar (KRI) All above outcomes measured at baseline (T0) and after that every 3 months (T1-T6) over a period of 19 months. | — |
Countries
Germany